Carlos Vendrell

PhD in Neuroscience at @Sauralab (Barcelona, Spain).

[nature @Nature]

Graduate students increasingly use artificial-intelligence tools to draft, code and search — but many fear it could erode the very skills a doctorate is meant to build

https://t.co/VhWQavdI7h

[Wall Street Wolverine @wallstwolverine]

Científicos españoles consiguen eliminar completamente el cáncer de páncreas gracias a la combinación de tres fármacos.

[Scholarship for PhD @ScholarshipfPhd]

"How is your thesis going?”–Ph.D. students’ perspectives on mental health and stress in academia

- 1 in 3 students above depression/anxiety thresholds
- Self-doubt + job insecurity = biggest predictors of poor mental health
- Bad supervision significantly worsens well-being
- Part-time work while doing PhD = burnout risk

The PhD mental health crisis isn't about weak students.

It's about systemic problems: exploitative labor conditions, poor supervision, job insecurity, and institutional neglect.

If you're struggling with your PhD, it's not your fault. These are predictable responses to broken systems.

[Carlos Vendrell @CVendrell11]

Grateful to have attended the XI INc Conference (UAB), where I presented my work on epitranscriptomic modulation in experimental models of Alzheimer’s disease, and proud for the 1st presentation award

It’s been an inspiring meeting surrounded by brilliant colleagues and science

[Sauralab @sauralab]

XII @INC_UAB Annual Scientific Conference. Members of our lab @CVendrell11 @xaviferol & Paula Sotillo are presenting their research projects funded by @CienciaGob @AgEInves @_BrightFocus @JPNDeurope

[nature @Nature]

A one-time gene therapy can markedly slow the progression of Huntington’s disease, potentially paving the way for the first ever treatment to alter the course of this rare, inherited brain disorder.

https://t.co/Im3kL0reQM

[Carlos Vendrell @CVendrell11]

It took me a day to process it: uniQure’s gene therapy for Huntington’s AMT-130 slowed disease progression by ~75% over 3 years.

So happy for patients and proud to have made a small contribution. A real step toward changing lives for so many families.

https://t.co/tosUmxiCUO

[uniQure @uniQure_NV]

Earlier today we announced that the pivotal Phase I/II study of our #genetherapy candidate AMT-130 in #huntingtonsdisease met its primary and a key secondary endpoint in the high-dose, with favorable trends across additional clinical measures. https://t.co/h2ALjhjqTL

[Sauralab @sauralab]

Last day in the lab of our talented research fellow @CapillaMD . All @INC_UAB will miss you !!! Lola has contributed to our understanding of #Alzheimer´s disease pathogenesis. See her 2025 Mol Psychiatry @NaturePortfolio paper: https://t.co/A6L1qlCu1P

[Carlos Vendrell @CVendrell11]

@MarPuigde @AgEInves @UBneuroscience Congratulations to you @MarPuigde and all the team!! Very well deserved 👏🏽👏🏽👏🏽

[Carlos Vendrell @CVendrell11]

Last Friday, we had the pleasure of welcoming Dr. Astrid Vallès to the @INC_UAB for a seminar organized by NeuroDocs.

She gave an inspiring talk on her work in gene therapy for CNS diseases and shared reflections on her career journey.

#NeuroDocs #WomenInScience
#Neuroscience

[Institut de Neurociències UAB @INC_UAB]

Great #incuabseminar today, by Dr Astrid Vallès, organized by Neurodocs. Dr. Vallès presented her work on developing gene-based therapeutics for Huntington’s Disease

[SVFH @SVFH_]

▶️ Proyecto EDULIPID: Intervención educativa para mejorar los resultados en salud en pacientes tratados con iPCSK9.

➡️ David Marín Delgado
🏥 Hospital General Universitario de Castellón

#CongresoSVFH2025
#JornadaResidentes

@Marin__David @FarmaciaHGUCS

[Sauralab @sauralab]

@sauralab @MarPuigde members @CVendrell11 @CapillaMD @Fraga_Uxia @CarlesSaura attending #ADPD2025 @adpdnet meeting in Vienna

[Carles A. Saura @CarlesSaura]

Great historical perspective of #presenilin loss-of-function in familial #Alzheimer disease by Prof. Jie Shen @harvardmed at #ADPD2025 @adpdnet meeting in Vienna. Honoured to be acknowledged after 20 years from my seminal studies in PS-deficient mice. 😀

[Sauralab @sauralab]

@CVendrell11 @sauralab presents his research project on m6A RNA regulators in human brain and #Alzheimer’s disease at #ADPD2025 @adpdnet meeting. Poster #599
Funded by @AgEInves @CienciaGob @INC_UAB @UABBarcelona @CarlesSaura

[Sauralab @sauralab]

@CapillaMD from @sauralab presenting her project on a new #Alzheimer’s APP/Tau mouse model at #ADPD2025 @adpdnet meeting. Funded by @_BrightFocus @AgEInves @CienciaGob @INC_UAB @UABBarcelona

[Mar Puigdellívol Canyadell @MarPuigde]

The Microglia Connectivity Lab from ⁦@UBneuroscience⁩ is presenting our latest findings at #ADPD2025 in Vienna! Visit our posters #480 & #673 ⁦@Fraga_Uxia⁩
We acknowledge the support of ⁦⁦@alzassociation⁩ ⁦⁦@AgEInves⁩ & collaborators⁦⁦@sauralab⁩

[Sauralab @sauralab]

Our postdoctoral fellow @CapillaMD @INC_UAB is presenting today her #Alzheimer’s research project on a new APP/Tau mouse model at #ADPD2025 meeting. Study supervised by @CarlesSaura . Stop by her poster and online talk shift 01-147

[Carles A. Saura @CarlesSaura]

Attending & participating at #ADPD2025 @adpdnet meeting in #Vienna with @sauralab @MarPuigde members @INC_UAB @UABBarcelona